ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase II Study of Erlotinib for Chemotherapy-Naive Patients With Advanced/Metastatic Non–Small-Cell Lung Cancer Who Are Ineligible for Platinum-Doublet Chemotherapy
Clinical Lung Cancer
◽
10.3816/clc.2009.n.063
◽
2009
◽
Vol 10
(5)
◽
pp. E14
◽
Cited By ~ 1
Author(s):
Dae Ho Lee
◽
Heung Tae Kim
◽
Jong Seok Lee
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Study
◽
Small Cell
◽
Small Cell Lung
◽
Doublet Chemotherapy
◽
Platinum Doublet
Download Full-text
Related Documents
Cited By
References
Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer
BMC Cancer
◽
10.1186/s12885-015-1350-6
◽
2015
◽
Vol 15
(1)
◽
Cited By ~ 5
Author(s):
Igor M Bondarenko
◽
Antonella Ingrosso
◽
Paul Bycott
◽
Sinil Kim
◽
Cristina L Cebotaru
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Study
◽
Small Cell
◽
Small Cell Lung
◽
Doublet Chemotherapy
Download Full-text
A randomized, phase II study of vandetanib maintenance for advanced or metastatic non-small-cell lung cancer following first-line platinum-doublet chemotherapy
Lung Cancer
◽
10.1016/j.lungcan.2013.08.027
◽
2013
◽
Vol 82
(3)
◽
pp. 455-460
◽
Cited By ~ 25
Author(s):
Jin Seok Ahn
◽
Ki Hyeong Lee
◽
Jong-Mu Sun
◽
Keunchil Park
◽
Eun-Suk Kang
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
Randomized Phase Ii
◽
Doublet Chemotherapy
◽
Platinum Doublet
Download Full-text
Interim analysis of a phase II study of induction weekly paclitaxel/carboplatin regimens followed by maintenance weekly paclitaxel for advanced and metastatic non[ndash ]small cell lung cancer
Seminars in Oncology
◽
10.1053/sonc.2001.27610
◽
2001
◽
Vol 28
(4L)
◽
pp. 14-16
Author(s):
Chandra P. Belani
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Interim Analysis
◽
Phase Ii Study
◽
Small Cell
◽
Weekly Paclitaxel
◽
Small Cell Lung
Download Full-text
Faculty of 1000 evaluation for A phase II study of bevacizumab and erlotinib as initial treatment for metastatic non-squamous, non-small cell lung cancer with serum proteomic evaluation.
F1000 - Post-publication peer review of the biomedical literature
◽
10.3410/f.717976259.793472648
◽
2013
◽
Author(s):
James Spicer
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Initial Treatment
◽
Phase Ii Study
◽
Small Cell
◽
Small Cell Lung
Download Full-text
A phase II study with gemcitabine and split-dose cisplatin in patients with advanced non-small cell lung cancer
Lung Cancer
◽
10.1016/j.lungcan.2006.06.013
◽
2006
◽
Vol 54
(1)
◽
pp. 57-62
◽
Cited By ~ 14
Author(s):
Jung Han Kim
◽
Dong Hun Lee
◽
Hyun Chun Shin
◽
Jung Hye Kwon
◽
Joo Young Jung
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Study
◽
Small Cell
◽
Small Cell Lung
◽
Split Dose
Download Full-text
115P Survival data from EMPOWER-Lung 4: Phase II study of cemiplimab plus ipilimumab in the second-line (2L) treatment of advanced non-small cell lung cancer (NSCLC)
Journal of Thoracic Oncology
◽
10.1016/s1556-0864(21)01957-2
◽
2021
◽
Vol 16
(4)
◽
pp. S760
Author(s):
B.Y. Shim
◽
S. Lee
◽
J. de Castro Carpeño
◽
C-H. Chiu
◽
M. Cobo
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Survival Data
◽
Phase Ii Study
◽
Small Cell
◽
Second Line
◽
Small Cell Lung
Download Full-text
Final survival results for the LURET phase II study of vandetanib in previously treated patients with RET-rearranged advanced non-small cell lung cancer
Lung Cancer
◽
10.1016/j.lungcan.2021.03.002
◽
2021
◽
Vol 155
◽
pp. 40-45
Author(s):
Kiyotaka Yoh
◽
Takashi Seto
◽
Miyako Satouchi
◽
Makoto Nishio
◽
Noboru Yamamoto
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Study
◽
Small Cell
◽
Small Cell Lung
◽
Previously Treated Patients
◽
Previously Treated
◽
Final Survival
Download Full-text
Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-Small Cell Lung Cancer: SQUAT trial (WJOG 12119L)
Clinical Lung Cancer
◽
10.1016/j.cllc.2021.04.006
◽
2021
◽
Author(s):
Akira Hamada
◽
Junichi Soh
◽
Akito Hata
◽
Kiyoshi Nakamatsu
◽
Mototsugu Shimokawa
◽
...
Keyword(s):
Lung Cancer
◽
Radiation Therapy
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Study
◽
Small Cell
◽
Small Cell Lung
◽
Stage Iiia
◽
Adjuvant Immunotherapy
Download Full-text
Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer
Cancer
◽
10.1002/1097-0142(19940815)74:4<1243::aid-cncr2820740411>3.0.co;2-d
◽
1994
◽
Vol 74
(4)
◽
pp. 1243-1252
◽
Cited By ~ 45
Author(s):
Margaret Deutsch
◽
Jeffrey Crawford
◽
Kenneth Leopold
◽
Walter Wolfe
◽
William Foster
◽
...
Keyword(s):
Lung Cancer
◽
Radiation Therapy
◽
Neoadjuvant Chemotherapy
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Study
◽
Small Cell
◽
Small Cell Lung
Download Full-text
Epirubicin in extensive small-cell lung cancer: A phase II study in previously untreated patients: A National Cancer Institute of Canada Clinical Trials Group Study
Lung Cancer
◽
10.1016/0169-5002(90)90224-a
◽
1990
◽
Vol 6
(3-4)
◽
pp. 139
Keyword(s):
Lung Cancer
◽
Clinical Trials
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
National Cancer Institute
◽
Phase Ii Study
◽
Small Cell
◽
Small Cell Lung
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close